Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses

Entry inhibitors, Human immunodeficiency virus type 1, Nicotinates of glycyrrhizic acid, SARS-CoV-2, Chlorocebus aethiops, COVID-19/drug therapy, Antiviral Agents/chemical synthesis, Glycyrrhizic Acid/chemistry, Humans, SARS-CoV-2/drug effects, HIV Infections/drug therapy, HIV-1/drug effects, Animals, Virus Replication, HeLa Cells, In Vitro Techniques, Vero Cells

ID: 35167213